Investigations of the Effects of Aprovel, Lipanor and Their Combination Onto the Endothelial Functions of Dyslipidemic Patients Measure by Laser Doppler Flow-Metry.
Phase of Trial: Phase IV
Latest Information Update: 17 Sep 2007
At a glance
- Drugs Ciprofibrate; Irbesartan
- Indications Dyslipidaemias; Hypertension
- Focus Pharmacodynamics
- Sponsors Sanofi
- 17 Sep 2007 Status changed from in progress to completed.
- 12 Sep 2006 New trial record.